Synkrino Biotherapeutics
Synkrino Biotherapeutics discovers drug targets by analyzing patients' immune systems to enable targeted therapeutics and clinical monitoring. It applies an AIDE Engine that uses neural networks and machine learning to measure immune tissue signals and repeatedly identify biologically valid targets. The company operates as a biotech platform (B2B SaaS-like discovery platform and therapeutics developer) serving healthcare providers, clinical researchers and biopharma partners. Synkrino is also adapting its analytic protocols toward a rapid, portable RNA virus screening tool for public health and clinical applications.
Synkrino Biotherapeutics
Synkrino Biotherapeutics discovers drug targets by analyzing patients' immune systems to enable targeted therapeutics and clinical monitoring. It applies an AIDE Engine that uses neural networks and machine learning to measure immune tissue signals and repeatedly identify biologically valid targets. The company operates as a biotech platform (B2B SaaS-like discovery platform and therapeutics developer) serving healthcare providers, clinical researchers and biopharma partners. Synkrino is also adapting its analytic protocols toward a rapid, portable RNA virus screening tool for public health and clinical applications.